Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03690752 · ClinicalTrials.gov registry record · NA

Adherence to Walking on an Alter G Anti-Gravity Treadmill

A NA study, sponsored by Texas Tech University.

Completed
Registry status
NA
Development phase
26
Enrollment target

NCT03690752 is a NA study that has completed, run by Texas Tech University. The registered enrollment target is 26 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03690752, a NA study, has completed, sponsored by Texas Tech University.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target

Study Summary

Several barriers to exercise are present that need to be addressed. Morbidly obese individuals experience more skin friction, urinary stress incontinence, knee pain, low back pain, and hip arthritis than the lean population, which may significantly impair their ability to adhere to an exercise regimen (6). Obesity and overweight also contribute to greater perceived effort, oxygen uptake, and less pleasure during treadmill exercise sessions (7). Recent theories suggest that a negative experience associated with exercise can significantly reduce the likelihood of engaging in future exercise sessions (8). Therefore, tools to reduce these barriers may improve outcomes for exercise-based interventions for morbid obesity. The Alter-G, an antigravity treadmill that alleviates body weight while subjects exercise, has potential to reduce pain and exertion during exercise. Overall, these treadmills have been found to be effective for weight loss in obese populations (10). However, although evidence suggests that the Alter-G would reduce pain and exertion, the effect of the Alter-G treadmill on exercise adherence in morbidly obese populations has not been studied. The hypothesis is that the adherence to and progression of the exercise routine of participants walking at a reduced percentage of their body weight will increase relative to those who must exercise at 100% of their body weight. A secondary hypothesis is that participants who use the Alter-G with the anti-gravity function will experience less pain and perceived exertion during exercise compared to those who exercise at 100% of their body weight. Finally, the investigators hypothesize that increased exercise adherence in those using the anti-gravity function of the Alter-G will lead to increased fitness and improved muscle function.

Interventions

  • DEVICE unweighting using Alter-G Anti-Gravity Treadmill
  • DEVICE normal weight using Alter-G Anti-Gravity Treadmill

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2017-09-09
Est. Completion 2018-10-01
Phase NA

Sponsor

Texas Tech University

69 total trials

What the Registry Record Tells You About NCT03690752

The ClinicalTrials.gov registry entry for NCT03690752 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University, which has 69 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which unweighting using Alter-G Anti-Gravity Treadmill is the first listed.

NCT03690752 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03690752 about?

NCT03690752 is a clinical study titled "Adherence to Walking on an Alter G Anti-Gravity Treadmill". Several barriers to exercise are present that need to be addressed. Morbidly obese individuals experience more skin friction, urinary stress incontinence, knee pain, low back pain, and hip arthritis than the lean population, which may significantly impair their ability to adhere to an exercise regim...

What is the current status of trial NCT03690752?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2017-09-09. Estimated completion is 2018-10-01.

What interventions are being tested in trial NCT03690752?

The interventions under investigation include: unweighting using Alter-G Anti-Gravity Treadmill (DEVICE), normal weight using Alter-G Anti-Gravity Treadmill (DEVICE).

Who is sponsoring clinical trial NCT03690752?

This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.